Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Silodosin (8mg) + Dutasteride (0.5mg)
Therapeutic Category
General and OTC medicines, Urology, Endocrinology, Nephrology
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹411/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sildodime D Capsule combines two potent medications, Silodosin and Dutasteride, in a sustained-release formulation. Silodosin is a selective alpha-1 adrenergic antagonist that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. Dutasteride is a 5-alpha-reductase inhibitor that reduces the size of the prostate by blocking the conversion of testosterone to dihydrotestosterone (DHT), which is responsible for prostate enlargement. This combination therapy is designed to provide symptomatic relief for men suffering from benign prostatic hyperplasia (BPH), also known as an enlarged prostate.
Sildodime D works by improving urinary flow, reducing symptoms of urgency, frequency, and incomplete bladder emptying. The sustained-release formulation allows for once-daily dosing, offering convenient management of BPH symptoms and potentially preventing further prostate enlargement.
Common side effects include dizziness, decreased libido, erectile dysfunction, fatigue, and ejaculation disorders. Rarely, it may cause allergic reactions, breast tenderness, or gynecomastia (enlarged breast tissue in men).
Sildodime D Capsule is indicated for the treatment of benign prostatic hyperplasia (BPH) in men, aimed at improving urinary flow and reducing the size of the prostate.
Consult a healthcare professional before using if you have liver disease, a history of prostate cancer, or a history of heart conditions.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Silodosin (8mg) Capsule
Composition : Omeprazole (20mg) Capsule
Composition : Levosulpiride (75mg) + Rabeprazole (20mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
Composition : Levosulpiride (75mg) + Esomeprazole (40mg)
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Oseltamivir Phosphate (75mg)
Composition : Levofloxacin (750mg)
Composition : Levofloxacin (500mg)
Composition : Levofloxacin (250mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sildodime D Capsule, containing Silodosin 8mg and Dutasteride 0.5mg, has strong demand in the urology and prostate care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their specialty urology portfolio.
Medical distributors and agencies can benefit from the consistent market demand for medicines used in benign prostatic hyperplasia (BPH), urinary symptoms, and prostate enlargement management. Sildodime D Capsule helps strengthen a comprehensive urology and chronic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sildodime D Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted urology and prostate care product range when partnering for Sildodime D Capsule distribution.
Medical distributors, stockists, and wholesalers interested in Sildodime D Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.